Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ERK1/2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | ERK1/2 |
| Key Genes/Proteins | 6-OHDA, Actin, ADAM17, ADRA2A, ADRA2B, AGING |
| Related Diseases | Aging, Als, ALS, Alzheimer |
graph TD
ERK1_2["ERK1/2"]
style ERK1_2 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
ERK1_2 -->|"interacts"| HSPA1A([HSPA1A])
ERK1_2 -->|"mediates"| Apoptosis["Apoptosis"]
ERK1_2 -->|"regulates"| Inflammation["Inflammation"]
ERK1_2 -->|"mediates"| Astrocyte_Activation["Astrocyte Activation"]
ERK1_2 -->|"mediates"| Microglia_Activation["Microglia Activation"]
ERK1_2 -->|"regulates"| neurodegeneration["neurodegeneration"]
ERK1_2 -->|"regulates"| ADAM17([ADAM17])
ERK1_2 -->|"activates"| Aging["Aging"]
ERK1_2 -->|"interacts"| Cancer["Cancer"]
PRDX1([PRDX1]) -->|"phosphorylates"| ERK1_2
TGN_020{"TGN-020"} -.->|"inhibits"| ERK1_2
AKT([AKT]) -.->|"inhibits"| ERK1_2
oxidative_stress(oxidative stress) -->|"regulates"| ERK1_2
LL37([LL37]) -->|"interacts"| ERK1_2
U0126{"U0126"} -.->|"inhibits"| ERK1_2
CaMKII([CaMKII]) -->|"activates"| ERK1_2
ADRA2B([ADRA2B]) -->|"activates"| ERK1_2
SEMA3F([SEMA3F]) -.->|"downregulates"| ERK1_2
AGING([AGING]) -->|"activates"| ERK1_2| Target | Relation | Type | Str |
|---|---|---|---|
| HSPA1A | interacts_with | gene | 0.90 |
| Apoptosis | mediates | process | 0.88 |
| Apoptosis | regulates | process | 0.85 |
| APOPTOSIS | associated_with | process | 0.85 |
| Inflammation | regulates | process | 0.85 |
| Apoptosis | associated_with | process | 0.80 |
| Microglia Activation | mediates | process | 0.78 |
| Astrocyte Activation | mediates | process | 0.78 |
| neurodegeneration | regulates | process | 0.70 |
| ADAM17 | regulates | gene | 0.70 |
| Als | activates | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Glioblastoma | regulates | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Neuropathy | transports | disease | 0.65 |
| Alzheimer | protects_against | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Parkinson | inhibits | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Ischemia | associated_with | disease | 0.65 |
| Encephalitis | associated_with | disease | 0.65 |
| Multiple Sclerosis | associated_with | disease | 0.65 |
| GSK-3Β | activates | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| RNA | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.60 |
| AMYLOID | inhibits | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PRDX1 | phosphorylates | protein | 0.85 |
| AKT | inhibits | gene | 0.80 |
| TGN-020 | inhibits | drug | 0.80 |
| FGF21 | activates | gene | 0.80 |
| LL37 | interacts_with | protein | 0.75 |
| oxidative stress | regulates | phenotype | 0.75 |
| U0126 | inhibits | drug | 0.72 |
| SEMA3F | downregulates | gene | 0.70 |
| oxidative stress | modulates | process | 0.70 |
| CaMKII | activates | protein | 0.70 |
| ADRA2B | activates | gene | 0.70 |
| IL-10 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| PARK2 | associated_with | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| TLR4 | activates | gene | 0.60 |
| OPA1 | activates | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| HSPA1A | inhibits | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| FGF | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| GFAP | inhibits | gene | 0.60 |
| CHRNA7 | inhibits | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| MEK | inhibits | gene | 0.60 |
| MAPK | therapeutic_target | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| DDX3X | inhibits | gene | 0.60 |
| SIRT7 | inhibits | gene | 0.60 |
| IBA1 | activates | gene | 0.60 |
| PI3K | regulates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| FGF1 | interacts_with | gene | 0.60 |
| PRDX1 | activates | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| ASTROCYTE | activates | gene | 0.60 |
| APOPTOSIS | associated_with | gene | 0.60 |
| APP | inhibits | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| AMYLOID | inhibits | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| RNA | inhibits | gene | 0.60 |
| NGF | activates | gene | 0.60 |
| MTORC1 | activates | gene | 0.60 |
| TLR | activates | gene | 0.60 |
| ASTROCYTES | activates | gene | 0.60 |
| STROKE | inhibits | gene | 0.60 |
| MYELIN | transports | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ERK1/2 in their description or question text
No additional research found